ACHFF (Arch Biopartners) OCF Margin %: 0.00% (As of Mar. 2026)


ACHFF Arch Biopartners Inc ACHFF
26 GF Score
Price $0.64
! 4 Warning Signs
View Full Analysis

What is Arch Biopartners OCF Margin %?

Arch Biopartners ACHFF +5.30% 26 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ACHFF with a GF Score™ of 26/100. The stock has 4 warning signs investors should review. Among 959 Biotechnology companies, Arch Biopartners ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Arch Biopartners's Cash Flow from Operations for the three months ended in Mar. 2026 was $-0.08 Mil. Arch Biopartners's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Arch Biopartners's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Arch Biopartners's current OCF Yield % is -1.71%.

The historical rank and industry rank for Arch Biopartners's OCF Margin % or its related term are showing as below:


ACHFF's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Arch Biopartners OCF Margin % Related Terms

Arch Biopartners OCF Margin % Historical Data

* Premium members only.

The historical data trend for Arch Biopartners's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Biopartners OCF Margin % Chart

Arch Biopartners Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Arch Biopartners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ACHFF
26GF Score
Arch Biopartners Inc ACHFF
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Biopartners OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Arch Biopartners's OCF Margin for the fiscal year that ended in Sep. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-1.145/0
= %

Arch Biopartners's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.079/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Arch Biopartners (ACHFF) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Arch Biopartners and its competitors. According to the industry distribution chart, Arch Biopartners ranks #999999 out of 959 companies in the Biotechnology industry.
Is Arch Biopartners' OCF Margin % too high?
Arch Biopartners' current OCF Margin % is 0.00%. Based on the distribution chart, Arch Biopartners ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Arch Biopartners has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Arch Biopartners' OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Arch Biopartners ranks #999999 out of 959 companies for OCF Margin %. This places Arch Biopartners in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Arch Biopartners and its competitors. Arch Biopartners's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Biopartners stock overvalued right now?
Arch Biopartners (ACHFF) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Arch Biopartners' overall GF Score™ is 26/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Arch Biopartners (ACHFF), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Biopartners Business Description

Other Exchanges 8HA:GermanyARCH:Canada
Address 545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
26GF Score

Get the complete analysis for ACHFF

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.64
Price